Panel explores insulin strategies to overcome ‘therapeutic inertia’ in type 2 diabetes
Viral Shah, MD, pointed to missed insulin doses as one of the main contributors to therapeutic inertia for these patients. Data from multiple studies indicate up to 30% of people with type 2 diabetes miss at least one basal insulin dose per month. Continuous glucose monitoring, connected insulin pens, and automated insulin delivery may be key to overcoming this challenge.
Read more